Hap Trading, LLC Aligos Therapeutics, Inc. Transaction History

Hap Trading, LLC

  • $872 Billion
  • Q3 2024

A detailed history of Hap Trading, LLC transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 16,000 shares of ALGS stock, worth $525,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,000
Holding current value
$525,600
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

Others Institutions Holding ALGS

# of Institutions
1
Shares Held
227K
Call Options Held
0
Put Options Held
0
View Full List

About Aligos Therapeutics, Inc.

ALGS Quotes by TradingView
  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $1.3B
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email